Advertisement
Study demonstrates potential for improving access
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients
How to screen for and manage treatment-triggered uveitis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In search of optimal imaging biomarkers, best methods for long-term follow-up
Growing public interest in hallucinogens highlights their therapeutic promise and potential perils
Research indicates strong rationale for expanding trial eligibility criteria
A three-step plan aimed at strengthening the institute’s infrastructure includes a renewed focus on mentorship
A study of the procedure’s efficacy is cause for reflection, not rejection
Dr. Aaron Gerds argues for more balance in safety reporting
Advertisement
Advertisement